Search results for "Immunity"

showing 10 items of 1537 documents

Quaking and miR-155 interactions in inflammation and leukemogenesis.

2015

Quaking (QKI) is a tumor-suppressor gene encoding a conserved RNA-binding protein, whose expression is downregulated in several solid tumors. Here we report that QKI plays an important role in the immune response and suppression of leukemogenesis. We show that the expression of Qki is reduced in lipopolysaccharide (LPS)-challenged macrophages, suggesting that Qki is a key regulator of LPS signaling pathway. Furthermore, LPS-induced downregulation of Qki expression is miR-155-dependent. Qki overexpression impairs LPS-induced phosphorylation of JNK and particularly p38 MAPKs, in addition to increasing the production of anti-inflammatory cytokine IL-10. In contrast, Qki ablation decreases Fas …

LipopolysaccharidesTime Factorsmedicine.medical_treatmentmedicine.disease_causeTransgenicMiceInnatePhosphorylationChronicB-LymphocytesLeukemiaRNA-Binding ProteinsU937 CellsLymphocyticCell biologyCytokineOncologyPhosphorylationCytokinesCLL; Glioblastoma; Inflammation; MiR-155; QKI; Animals; Apoptosis Regulatory Proteins; B-Lymphocytes; Case-Control Studies; Cytokines; Humans; Immunity Innate; Inflammation; Leukemia Lymphocytic Chronic B-Cell; Lipopolysaccharides; Macrophages; Mice; Mice Transgenic; MicroRNAs; Mitogen-Activated Protein Kinases; Phosphorylation; RAW 264.7 Cells; RNA-Binding Proteins; Signal Transduction; Time Factors; Transfection; U937 Cells; OncologySignal transductionMitogen-Activated Protein KinasesSignal Transductionp38 mitogen-activated protein kinasesOncology and CarcinogenesisMice TransgenicTransfectionNOmiR-155miR-155Downregulation and upregulationmicroRNAmedicineAnimalsHumansInflammationQKIbusiness.industryMacrophagesB-CellImmunityglioblastomaLeukemia Lymphocytic Chronic B-CellImmunity InnateMicroRNAsRAW 264.7 CellsCase-Control StudiesImmunologyCarcinogenesisbusinessApoptosis Regulatory ProteinsCLLPriority Research Paper
researchProduct

CiC3-1a-Mediated Chemotaxis in the Deuterostome Invertebrate Ciona intestinalis (Urochordata)

2003

Abstract Deuterostome invertebrates possess complement genes, and in limited instances complement-mediated functions have been reported in these organisms. However, the organization of the complement pathway(s), as well as the functions exerted by the cloned gene products, are largely unknown. To address the issue of the presence of an inflammatory pathway in ascidians, we expressed in Escherichia coli the fragment of Ciona intestinalis C3-1 corresponding to mammalian complement C3a (rCiC3-1a) and assessed its chemotactic activity on C. intestinalis hemocytes. We found that the migration of C. intestinalis hemocytes toward rCiC3-1a was dose dependent, peaking at 500 nM, and was specific for…

Lipopolysaccharidescomplement system ascidiansHemocytesMolecular Sequence DataIn situ hybridizationPertussis toxinimmunologyHemolymphEscherichia coliAnimalsImmunology and AllergyCiona intestinalisAmino Acid SequencePeptide sequenceinnate immunityInflammationCell-Free SystemChemotactic FactorsbiologyImmune SeraRiboprobeChemotaxisAnatomybiology.organism_classificationRecombinant ProteinsComplement systemCell biologyCiona intestinalisChemotaxis LeukocyteHemocyte migrationPertussis ToxinCell Migration InhibitionComplement C3a
researchProduct

Tiratricol neutralizes bacterial endotoxins and reduces lipopolysaccharide-induced TNF-alpha production in the cell.

2008

Contains fulltext : 70610.pdf (Publisher’s version ) (Closed access) The screening of a commercially available library of compounds has proved a successful strategy for the identification of a lead compound in a drug discovery programme. Here, we analysed 880 off-patent drugs, which initially comprised the Prestwick Chemical library, as sources of bacterial endotoxin neutralizers. We identified 3,3',5-triiodo-thyroacetic acid (tiratricol) as a non-antibacterial compound that neutralizes the toxic lipopolysaccharide.

LipopolysaccharidesendotoxinLipopolysaccharideCelllipopolysaccharide-antagonistsBiology:Enginyeria dels materials [Àrees temàtiques de la UPC]BiochemistryCell LineChemical libraryMicrobiologyLipid ASepsissepsisMiceStructure-Activity Relationshipchemistry.chemical_compoundtumour necrosis factor-alphaDrug DiscoveryEscherichia colimedicineAnimalsDrugs--Designlipid APharmacologyTriiodothyroacetic acidMedicaments -- DissenyTumor Necrosis Factor-alphaDrug discoveryOrganic Chemistrylipopolysaccharidetumour necrosis factor-amedicine.diseaseAnti-Bacterial AgentsEndotoxinsmedicine.anatomical_structurechemistryTriiodothyronineMolecular Medicineseptic shockLead compoundImmunity infection and tissue repair [NCMLS 1]
researchProduct

Plasma PLTP (phospholipid-transfer protein): an emerging role in ‘reverse lipopolysaccharide transport’ and innate immunity

2011

Plasma PLTP (phospholipid-transfer protein) is a member of the lipid transfer/LBP [LPS (lipopolysaccharide)-binding protein] family, which constitutes a superfamily of genes together with the short and long PLUNC (palate, lung and nasal epithelium clone) proteins. Although PLTP was studied initially for its involvement in the metabolism of HDL (high-density lipoproteins) and reverse cholesterol transport (i.e. the metabolic pathway through which cholesterol excess can be transported from peripheral tissues back to the liver for excretion in the bile), it displays a number of additional biological properties. In particular, PLTP can modulate the lipoprotein association and metabolism of LPS …

Lipopolysaccharidesmedicine.medical_specialtyInflammationPluncBiologyBiochemistryLipopolysaccharide transportchemistry.chemical_compoundInternal medicinePhospholipid transfer proteinmedicineAnimalsBileHumansMolecular Targeted TherapyPhospholipid Transfer ProteinsInnate immune systemCholesterolReverse cholesterol transportShock SepticImmunity InnateEndocrinologyLiverchemistrylipids (amino acids peptides and proteins)medicine.symptomMetabolic Networks and PathwaysLipoproteinBiochemical Society Transactions
researchProduct

States of Exception: Auto-immunity and the Body Politic in Shakespeare’s Coriolanus

2010

The essay starts by referring to a central moment in Shakespeare’s Coriolanus, when the Roman hero reacts to his banishment by banishing: “I banish you!" (3.3.123). These lines, the essay argues, provide, in a condensed form, a radical shift of perspective on the question of the boundaries of Rome: how far does Rome extend? Can Rome banish herself ? Does Rome move with Coriolanus as he moves “elsewhere” (3. 3. 135)? They also force the audience to reconsider the "nature" of the political decision that leads to the ban. Taking its cue from this line, the essay shows that the question of boundaries in Coriolanus is intimately connected with the uncanny logic of "auto-immunity" which affects R…

LiteratureHistoryImmunitybusiness.industryBody politicShakespeare Coriolanus Auto-immunity Derrida masculinity Homoeroticism body politic exceptionbusiness
researchProduct

Cationic Nanohydrogel Particles for Therapeutic Oligonucleotide Delivery.

2017

Short pharmaceutical active oligonucleotides such as small interfering RNA (siRNA) or cytidine-phosphate-guanosine (CpG) are considered as powerful therapeutic alternatives, especially to medicate hard-to-treat diseases (e.g., liver fibrosis or cancer). Unfortunately, these molecules are equipped with poor pharmacokinetic properties that prevent them from translation. Well-defined nanosized carriers can provide opportunities to optimize their delivery and guide them to their site of action. Among several concepts, this Feature Article focuses on cationic nanohydrogel particles as a universal delivery system for small anionic molecules including siRNA and CpG. Cationic nanohydrogels are deri…

Liver CirrhosisSmall interfering RNAPolymers and PlasticsLiver fibrosisNanoparticleEpitopes T-LymphocyteBioengineeringNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesBiomaterialsImmunomodulationMiceIn vivoCationsMaterials ChemistryAnimalsHumansRNA Small InterferingDrug CarriersOligonucleotideChemistryMucin-1Cationic polymerizationHydrogels021001 nanoscience & nanotechnologyIn vitroImmunity Innate0104 chemical sciencesCpG siteOligodeoxyribonucleotidesMethacrylatesNanoparticles0210 nano-technologyBiotechnologyMacromolecular bioscience
researchProduct

Pre-conception maternal helminth infection transfers via nursing long-lasting cellular immunity against helminths to offspring

2019

Mothers transfer immune cells via breastfeeding to provide offspring with long-term protection from parasitic infection.

Long lastingCD4-Positive T-LymphocytesMaleCellular immunityOffspring[SDV]Life Sciences [q-bio]animal diseasesImmunologyAntibodies Helminthchemical and pharmacologic phenomenaReceptors Cell SurfaceBiology03 medical and health sciences0302 clinical medicineImmune systemTh2 CellsNursingImmunityPregnancymedicineHelminthsAnimalsLactationImprinting (psychology)Research Articles030304 developmental biologyStrongylida Infections0303 health sciencesPregnancyB-LymphocytesImmunity CellularMice Inbred BALB CMultidisciplinarySciAdv r-articlesbiochemical phenomena metabolism and nutritionmedicine.disease3. Good healthAnimals SucklingMice Inbred C57BLbacteriaFemaleNippostrongylusImmunity Maternally-Acquired030215 immunologyResearch ArticleScience Advances
researchProduct

Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests prim…

1998

ABSTRACT Cytomegalovirus (CMV) infection during the transient immunodeficiency after bone marrow transplantation (BMT) develops into disease unless antiviral CD8 T cells are restored in due course. Histoincompatibility between donor and recipient is associated with increased risk. Complications may include a rejection response against the foreign major histocompatibility complex (MHC) antigens and a lack of antiviral control resulting from a misfit between donor-derived T cells and the antigenic viral peptides presented in recipient tissues. Here we have established a murine model of CMV disease after experimental BMT performed across a single MHC class I disparity. Specifically, BALB/c bon…

Lung DiseasesAdoptive cell transferImmunologyAntigen-Presenting CellsViral Pathogenesis and ImmunityCD8-Positive T-LymphocytesMajor histocompatibility complexMicrobiologyMajor Histocompatibility ComplexChimera (genetics)MiceAntigenVirologyMHC class ImedicineCytotoxic T cellAnimalsAntigen-presenting cellMice Inbred BALB CBone TransplantationbiologyChimeraVirologymedicine.anatomical_structureInsect ScienceImmunologyCytomegalovirus Infectionsbiology.proteinBone marrow
researchProduct

Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection

2004

Chronic Chlamydia pneumoniae infection and autoimmunity to heat shock protein 60 (Hsp60) have both been documented to be associated with atherosclerosis. Herein, we studied the effects of C. pneumoniae infection and a diet with a low-cholesterol supplement on the development of autoantibodies to mouse Hsp60 and early lipid lesions in the aortic valve of C57BL/6JBom mice. In addition, pulmonary infection was investigated. C57BL/6JBom mice were given one to three C. pneumoniae inoculations and fed either a regular diet or a diet enriched with 0.2% cholesterol. Autoantibody responses against mouse Hsp60 developed in both diet groups when the mice were infected with C. pneumoniae and in uninfec…

Lung DiseasesAutoimmunity030204 cardiovascular system & hematologymedicine.disease_causeCholesterol DietaryMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHeat shock proteinmedicineAnimalsChlamydiaceae030304 developmental biologyFoam cell0303 health sciencesChlamydiabiologyCholesterolAutoantibodyChaperonin 60Chlamydia InfectionsChlamydophila pneumoniaebiology.organism_classificationmedicine.disease3. Good healthchemistryChlamydophila pneumoniaeAortic ValveImmunologylipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineLipoproteinAtherosclerosis
researchProduct

SPARC regulation of PMN clearance protects from pristane induced lupus and rheumatoid arthritis

2020

AbstractOne step along the pathogenesis of Systemic lupus erythematosus (SLE) is associated with polymorphonuclear leukocyte (PMN) death and their ineffective removal by M2-macrophages. The secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein with unexpected immunosuppressive function in M2-macrophages and myeloid cells. To investigate the role of SPARC in autoimmunity, we adopted a pristane–induced model of lupus in mice, which recapitulates clinical manifestations of human SLE. Sparc-/- mice developed earlier and more severe renal disease, lung and liver parenchymal damage than the WT counterpart. Most prominently, Sparc-/- mice had anticipated and severe occurr…

LungSystemic lupus erythematosusbusiness.industryMatricellular proteinArthritisDendritic cellmedicine.diseasemedicine.disease_causeAutoimmunityPathogenesismedicine.anatomical_structureRheumatoid arthritisImmunologymedicineCancer researchMacrophagebusiness
researchProduct